Mainz Biomed

About:

Mainz BioMed is a molecular genetic diagnostics company developing market-ready molecular genetic diagnostic solutions.

Description:

Mainz BioMed primarily operates as a molecular genetic diagnostics company. It develops market-ready molecular genetic diagnostic solutions for life-threatening conditions.

Total Funding Amount:

$77.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Mainz, Rheinland-Pfalz, Germany

Founded Date:

2021-01-01

Contact Email:

info(AT)mainz-biomed.com

Founders:

Guido Baechler

Number of Employees:

51-100

Last Funding Date:

2023-11-13

IPO Status:

Public

Industries: